Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-22

Clinical Trial Update: Safety and Efficacy of Insulin Aspart vs. Regular Human Insulin in Gestational Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial comparing insulin aspart with regular human insulin in gestational diabetes has completed, evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin aspart (insulin aspart)
  • Regular human insulin (human insulin (regular))

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Gestational Diabetes | Phase 3 | Status: COMPLETED